“It’s not a certainty, but the plan — and I feel pretty confident — should make it such that by June, everybody could have been immunized in the U.S.,” Moncef Slaoui, PhD, the head of Operation Warp Speed, told the station.
Dr. Slaoui also predicted that Pfizer and Moderna will be the first drugmakers to submit their vaccine candidate to the FDA for emergency use authorization, saying he thinks they will seek the approval in November or December. He also said 20 million to 40 million doses will be stockpiled and ready to distribute to priority citizens if a COVID-19 vaccine is authorized before the end of the year.
More articles on pharmacy:
Trump’s $200 Medicare drug card plan may violate election law, HHS says
Widespread vaccine distrust is uniquely American, study finds
Health policy experts urge US to release all COVID-19 vaccine clinical trial protocols
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
